Point-of-Care Test Shows Early Promise for Diagnosing Neurosyphilis
The point-of-care Dual Path Platform (DPP®) assay may be an inexpensive tool for the diagnosis of neurosyphilis.
Bacterial Infections
C difficile Risk and Antibiotic Prescription Choices
Large variations in Clostridioides difficile infection risk resulting from antibiotic courses used for the same indications were identified.
Decreasing Prevalence of H pylori and Associated Gastric and Duodenal Ulcers
The prevalence of H pylori infection continues to fall in the general population with only 16% of all gastric and 25% of all duodenal patients with ulcer harboring H pylori.
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
Adherence to antimalarials may offer a protective effect against type 2 diabetes mellitus among patients with systemic lupus erythematosus.
Tobramycin/Dexamethasone Suspension Available for Inflammatory Eye Conditions With Bacterial Infection
Tobradex ST contains tobramycin, an antibacterial drug, and dexamethasone, a potent corticosteroid.
Case Highlights Need for Adequate Neutrophil Count and Function in the Clearance of E coli Bacteremia
Study shows ST-167, ST-940, and the isolate with an unidentifiable sequence type were cultured from blood and carried the blaNDM-5 gene, conferring phenotypic carbapenem resistance.
Exebacase Gains Breakthrough Therapy Status for MRSA Bacteremia, Including Right-Sided Endocarditis
Exebacase is a novel, recombinantly-produced lysin (cell wall hydrolase enzyme), that targets the peptidoglycan cell wall.
Changes in Microbiota Predictive of Recurrent C Difficile Infection Risk
Features of fecal microbiota at baseline and after antibiotic therapy may be predictive of recurrent Clostridiodes difficile infection in patients with and without ulcerative colitis.
Escherichia coli and the Progression of Diabetes Mellitus: A Review
The increase in incidence of T1DM may not be solely a result of genetics and environmental factors, but also that of gut microbiota.
Dual Therapy With Vonoprazan, Amoxicillin Effective For Helicobacter pylori
Dual therapy with vonoprazan and low-dose amoxicillin had similar efficacy to triple-drug treatment for the eradication of Helicobacter pylori.
Next post in Antibiotics, Antimicrobial Resistance
